NCT03338049 (AIO) is a NA clinical trial of Veran System in Lung Cancer, sponsored by Veran Medical Technologies.

Who is sponsoring NCT03338049?

NCT03338049 is sponsored by Veran Medical Technologies.

What drugs are being tested in NCT03338049?

Interventions in NCT03338049: Veran System.

What condition does NCT03338049 study?

NCT03338049 studies Lung Cancer.

Is NCT03338049 still recruiting?

NCT03338049 is currently completed. Last updated 19 May 2020.

Last reviewed 2020-05-19 · How we verify

NCT03338049: AIO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

All in One Study: A Prospective Trial of Electromagnetic Navigation for Biopsy of Pulmonary Nodules

Completed NA Last updated 19 May 2020

What this trial tests

NA trial testing Veran System in Lung Cancer in 150 participants. Completed in 1 December 2019.

Timeline

14 February 2018

Primary endpoint
29 October 2019

1 December 2019

Quick facts

Lead sponsor	Veran Medical Technologies
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	150
Start date	14 February 2018
Primary completion	29 October 2019
Estimated completion	1 December 2019
Sites	9 locations across United States

Drugs / interventions tested

Veran System

Conditions studied

Lung Cancer — all drugs for Lung Cancer →

Sponsor

Veran Medical Technologies

Who can join

21 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multi-center, non-randomized, single-arm, prospective trial to evaluate a staged sampling methodology designed to maximize the diagnostic yield of lung biopsy in a single procedure setting.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Virtual or reality: divergence between preprocedural computed tomography scans and lung anatomy during guided bronchoscopy.
Pritchett MA, Bhadra K, Calcutt M, Folch E. · · 2020 · cited 96× · PMID 32395297 · DOI 10.21037/jtd.2020.01.35
A Multicenter, Single-Arm, Prospective Trial Assessing the Diagnostic Yield of Electromagnetic Bronchoscopic and Transthoracic Navigation for Peripheral Pulmonary Nodules.
Thiboutot J, Pastis NJ, Akulian J, Silvestri GA, et al · · 2023 · cited 22× · PMID 37582154 · DOI 10.1164/rccm.202301-0099oc
Safety and diagnostic performance of pulmonologists performing electromagnetic guided percutaneous lung biopsy (SPiNperc).
Mallow C, Lee H, Oberg C, Thiboutot J, et al · · 2019 · cited 20× · PMID 30675961 · DOI 10.1111/resp.13471
Diagnostic accuracy and safety of electromagnetic navigation transthoracic needle biopsy under moderate sedation for the diagnosis of peripheral pulmonary lesions.
Kim S, Kim N, Chung S, Kim J, et al · · 2023 · cited 5× · PMID 37577320 · DOI 10.21037/tlcr-23-111
Pragmatic Studies in Interventional Pulmonology: Two Steps Forward, One Step Back, but an Imminent Leap Forward. Introducing IPOG, the Interventional Pulmonary Outcome Group.
Maldonado F, Yarmus L. · · 2019 · cited 5× · PMID 31233469 · DOI 10.1097/lbr.0000000000000575

Verify or expand the search:

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Other Veran Medical Technologies trials

Trials by the same sponsor.

NCT04066699 — Percutaneous Localization: Open-label Registry of Thoracic Surgery · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03338049 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Veran Medical Technologies
Last refreshed: 19 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03338049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing